38
Participants
Start Date
April 1, 2019
Primary Completion Date
January 30, 2025
Study Completion Date
January 30, 2025
rVWF
Recombinant von Willebrand factor
rFVIII
Recombinant Factor VIII
Hospital Universitario La Paz, Madrid
Medical University of South Carolina (MUSC), Charleston
University of Florida College of Medicine, Gainesville
Ege University Medical Faculty, Izmir
Ege University Medical Faculty, Izmir
Nationwide Children's Hospital, Columbus
Rainbow Babies and Children's Hospital, Cleveland
Cincinnati Children's Hospital Medical Center, Cincinnati
Hospital Universitari i Politecnic La Fe, Valencia
Indiana Hemophilia and Thrombosis Center, Indianapolis
Azienda Ospedaliera Universitaria Careggi, Florence
Ondokuz Mayis Univ. Med. Fac., Samsun
Groupement Hospitalier Est- Hôpital Louis Pradel, Bron
Arkansas Children's Hospital Research Institute, Little Rock
Hôpital Necker - Enfants Malades, Paris
University of Colorado Health, Aurora
Groupement Hospitalier Sud - Hôpital Bicêtre, Le Kremlin-Bicêtre
"FSBI of Science Kirov Scientific and Research Institute of Hematology and Blood Transfusion of FMBA", Kirov
"SAIH Kemerovo Regional Clinical Hospital", Kemerovo
AKH - Medizinische Universität Wien, Vienna
Hopital Cardiologique - CHU Lille, Lille
Groupe Hospitalier Pellegrin - Hôpital Pellegrin, Gironde
Klinikum der Johann Wolfgang Goethe-Universitaet, Frankfurt
Werlhof-Institut GmbH, Hanover
Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico, Milan
Azienda Ospedaliera Pediatrica Santobono Pausillipon, Napoli
Ospedale Pediatrico Bambino Gesù, Roma
Istanbul University Oncology Institute, Istanbul
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma
Azienda Ospedaliera Universitaria Policlinico Umberto I - Università di Roma La Sapienza, Roma
Erasmus Medisch Centrum, Rotterdam
Erasmus Medisch Centrum, Rotterdam
Hospital General Universitario de Alicante, Alicante
Takeda Development Center Americas, Inc.
INDUSTRY
Baxalta now part of Shire
INDUSTRY